Reviewing CATIE for clinicians: Balancing benefit and risk using evidence-based medicine tools

Current Medical Research and Opinion

Volumn 23, Issue 10, 2007, Pages 2551-2557

  Karagianis, Jamie ^a,b   Rosenbluth, Michael ^c   Tohen, Mauricio ^a,d   Ascher Svanum, Haya ^a,e   Treuer, Tamas ^a   De Lima, Mauricio Silva ^a,f   Citrome, Leslie ^g,h  

^a ELI LILLY AND COMPANY   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c TORONTO EAST GENERAL HOSPITAL   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Atypical antipsychotic; CATIE; LHH; NNT; Olanzapine; Quetiapine; Risperidone; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

CLINICAL PRACTICE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HUMAN; INTERVENTION STUDY; REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT GAIN;

EID: 35648936485     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233269     Document Type: Review

References (10)

1. Lieberman JA, Stroup TS, McEvoy JP et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23
2. Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003;29:15-31
3. Straus SE. Individualizing treatment decisions. The likelihood of being helped or harmed. Eval Health Prof 2002;25:210-24
4. Muir Gray JA. Evidence-Based Healthcare: How to Make Heath Policy and Management Decisions. London: Churchill Livingstone, 1997
5. Gray GE, Pinson LA. Evidence-based medicine and psychiatric practice. Psychiatr Q 2003;74:387-99
6. Pinson L, Gray GE. Psychopharmacology: number needed to treat: an underused measure of treatment effect. Psychiatr Serv 2003;54:145-6, 154
7. Citrome L, Stroup TS. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians? Int J Clin Pract 2006;60:933-40
8. Gray GE. Concise Guide to Evidence Based Psychiatry. Arlington, VA: American Psychiatric Publishing Inc., 2004
9. DiCenso A. Clinically useful measures of the effects of treatment. Evid Based Nurs 2001;4:36-9
10. Lorenz WF. Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry 1922;8:184-96